Tonix Pharmaceuticals Holding (TNXP) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Tonix Pharmaceuticals Holding Corp   (NASDAQ: TNXP)
 

Tonix Pharmaceuticals Holding Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Tonix Pharmaceuticals Holding 's inventory turnover ratio sequentially decreased to 0.83 in the second quarter 2026, unsurprisingly, as the Tonix Pharmaceuticals Holding markets continue to deteriorate, and TNXP's faces growing challenges to bring down its inventories. Tonix Pharmaceuticals Holding 's average inventory processing period in the Jun 30 2026 quarter, has increased to 440 days, from 268 days, in the Mar 31 2026 quarter.

Within Healthcare sector 331 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1461 in the first quarter 2026, to 1762.

TNXP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Tonix Pharmaceuticals Holding Corp Market Share?

What is Inventory Turnover Ratio?




TNXP Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 22.39 % -55.2 % -28.48 % -27.76 % -36.7 %
Y / Y Cost of Sales Growth -78.51 % 67.34 % -10.57 % -12.09 % -2.82 %
Inventory Turnover Ratio (TTM) 0.83 1.36 1.03 0.96 0.91
TNXP's Total Ranking # 1762 # 1461 # 1365 # 1413 # 1413
Average inventory processing period 440 268 355 381 400
Seq. Inventory Growth 100.99 % -39.38 % 4.96 % -4.29 % -26.43 %
Seq. Cost of Sales Growth -55.45 % 49.15 % -22.6 % -58.22 % 246.98 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 101
Healthcare Sector # 332
Overall Market # 1762

Inventory Turnover Ratio Statistics
High Average Low
1.36 0.88 0.48
(Mar 31 2026)   (Mar 31 2024)




Financial Statements
Tonix Pharmaceuticals Holding 's Inventories $ 7 Millions Visit TNXP's Balance sheet
Tonix Pharmaceuticals Holding 's Cost of Revenues TTM $ 5 Millions Visit TNXP's Income Statement
What are TNXP's Sales? Visit TNXP's Sales by Segment

Other Inventory Turnover Ratios
Tonix Pharmaceuticals Holding 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TNXP's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TNXP's Competitors
Inventory Turnover Ratio for TNXP's Suppliers
Inventory Turnover Ratio for TNXP's Customers

You may also want to know
TNXP's Sales Growth Rates TNXP's Pe Price to earnings ratio TNXP's Receivables Turnover Ratio TNXP's Stock Quote
TNXP's Net Income Growth Rates TNXP's Ps Price to Sales ratio TNXP's Sales per Employee TNXP's Asset Turnover Ratio
TNXP's Net Margin TNXP's Pb Price to Book ratio TNXP's Financial Strength Ratios TNXP's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Alpha Pro Tech Ltd   1.76 $ 38.696  Millions$ 22  Millions
Tenet Healthcare Corp  1.76 $ 605.000  Millions$ 344  Millions
Tenon Medical Inc   1.76 $ 1.763  Millions$ 1  Millions
Iradimed Corporation  1.76 $ 20.839  Millions$ 12  Millions
Utah Medical Products Inc  1.75 $ 14.771  Millions$ 8  Millions
Elutia Inc   1.75 $ 4.337  Millions$ 2  Millions
Axsome Therapeutics Inc   1.73 $ 52.530  Millions$ 30  Millions
Vycor Medical Inc   1.72 $ 0.301  Millions$ 0  Millions
Harvard Bioscience Inc   1.71 $ 37.097  Millions$ 22  Millions
Quanterix Corporation  1.69 $ 87.760  Millions$ 52  Millions
Haemonetics Corporation  1.68 $ 553.577  Millions$ 329  Millions
Conmed Corporation  1.68 $ 606.349  Millions$ 362  Millions
Stryker Corp  1.67 $ 9,049.000  Millions$ 5,405  Millions
Atricure Inc   1.67 $ 134.975  Millions$ 81  Millions
Ceribell Inc   1.66 $ 11.159  Millions$ 7  Millions
The Cooper Companies Inc   1.65 $ 1,443.300  Millions$ 875  Millions
Procept Biorobotics Corporation  1.65 $ 120.119  Millions$ 73  Millions
Sanuwave Health Inc   1.62 $ 10.421  Millions$ 6  Millions
Bio rad Laboratories Inc   1.62 $ 1,245.200  Millions$ 769  Millions
Innovative Eyewear Inc   1.61 $ 2.634  Millions$ 2  Millions
Ultragenyx Pharmaceutical Inc   1.60 $ 87.336  Millions$ 55  Millions
Pfizer Inc  1.60 $ 17,084.000  Millions$ 10,684  Millions
Capsovision Inc   1.60 $ 5.736  Millions$ 4  Millions
Lakeland Industries Inc   1.59 $ 128.669  Millions$ 81  Millions
Integra Lifesciences Holdings Corp  1.59 $ 783.084  Millions$ 492  Millions
Ss Innovations International Inc  1.58 $ 28.689  Millions$ 18  Millions
Rapid Micro Biosystems Inc   1.57 $ 29.477  Millions$ 19  Millions
Urogen Pharma Ltd   1.54 $ 17.278  Millions$ 11  Millions
Bausch and Lomb Corp  1.54 $ 1,523.000  Millions$ 989  Millions
Staar Surgical Co  1.53 $ 79.388  Millions$ 52  Millions

Date modified: 2026-09-08T22:38:38+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.